ViaDerma, Inc. engages with the manufacturing and sales of pharmaceutical related products. The company is headquartered in Las Vegas, Nevada. The company went IPO on 2008-06-10. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The firm also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and toenail fungus. The products are based on a patent pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The firm utilizes a specific trade secret formulation system in the manufacture of all products. The Company’s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Company’s subsidiary is ViaDerma, II Inc.
Follow-Up Questions
¿Cuál es el ratio P/E de Viaderma Inc (VDRM)?
El ratio P/E de Viaderma Inc es 0.0924
¿Quién es el CEO de Viaderma Inc?
Rui Sheng Liu es el President de Viaderma Inc, se unió a la empresa desde 2009.
¿Qué tal es el rendimiento del precio de la acción VDRM?
El precio actual de VDRM es de $0.0002, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Viaderma Inc?
Viaderma Inc pertenece a la industria Pharmaceuticals y el sector es Health Care
¿Cuál es la capitalización bursátil de Viaderma Inc?
La capitalización bursátil actual de Viaderma Inc es $246.7K
